TLR9 Antikörper (AA 268-284)
Kurzübersicht für TLR9 Antikörper (AA 268-284) (ABIN337069)
Target
Alle TLR9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Bindungsspezifität
- AA 268-284
- 
                                            Marke
- IHC-plus™
- 
                                            Spezifität
- KLH-conjugated synthetic peptide corresponding to amino acids 268-284 of human TLR9 isoform A (Genbank accession no. AAF78037).
- 
                                            Homologie
- Percent identity by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Monkey (100%) Chimpanzee, Marmoset (94%) Sheep, Goat, Zebu, Bovine, Horse (82%).
- 
                                            Aufreinigung
- Protein G purified
- 
                                            Immunogen
- 
                        This antibody was developed against KLH-conjugated synthetic peptide corresponding to amino acids 268-284 (CPRHFPQLHPDTFSHLS) of human TLR9 isoform A (Genbank accession no. AAF78037). Percent identity by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Monkey (100%), Chimpanzee, Marmoset (94%), Sheep, Goat, Zebu, Bovine, Horse (82%).
 Type of Immunogen: Synthetic peptide - KLH conjugated
- 
                                            Isotyp
- IgG1 kappa
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        Approved: Flo, IHC, IHC-Fr (10 - 20 μg/mL), IHC-P (5 μg/mL), WB (1 - 3 μg/mL)
 Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 5 μg/mL.
- 
                                            Kommentare
- 
                        Target Species of Antibody: Human 
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- Lot specific
- 
                                            Buffer
- PBS, 0.05 % sodium azide.
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Handhabung
- Avoid repeated freezing and thawing.
- 
                                            Lagerung
- 4 °C,-20 °C
- 
                                            Informationen zur Lagerung
- 4°C or -20°C, Avoid freeze-thaw cycles.
 
- 
                                            
- 
    - TLR9 (Toll-Like Receptor 9 (TLR9))
- 
                                            Andere Bezeichnung
- TLR9
- 
                                            Hintergrund
- 
                        Name/Gene ID: TLR9
 Family: Toll-like Receptor
 Synonyms: TLR9, CD289, CD289 antigen, Scri2a, Toll-like receptor 9
- 
                                            Gen-ID
- 54106
- 
                                            UniProt
- Q9NR96
- 
                                            Pathways
- TLR Signalweg, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Toll-Like Receptors Cascades
 Target
- 
                    
 
                                     
                                     
                                    